Paris, France

Telmo Figueiredo

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Institut Curie. Active years: 2008.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Telmo Figueiredo

Introduction

Telmo Figueiredo is a notable inventor based in Paris, France. He has made significant contributions to the field of photodynamic therapy through his innovative research and development of porphyrin derivatives. His work focuses on creating compounds that can effectively target and impair biological materials, such as viruses and tumoral cells.

Latest Patents

Figueiredo holds a patent for "Porphyrin derivatives for photodynamic therapy." This invention relates to porphyrin compounds that are utilized to destroy or impair the functioning of target biological materials in photodynamic therapy. The invention is particularly effective against viruses, tumoral cells, bacteria, and tumorous tissues. It also encompasses compositions containing these compounds and a method to photosensitize and destroy or impair the functioning of such target biological materials in vitro. He has 1 patent to his name.

Career Highlights

Throughout his career, Telmo Figueiredo has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and Institut Curie. His research has contributed to advancements in medical therapies, particularly in the treatment of cancer and infectious diseases.

Collaborations

Figueiredo has collaborated with esteemed colleagues, including Danielle Carrez and Philippe Maillard. These partnerships have further enhanced the impact of his research and innovations in the field.

Conclusion

Telmo Figueiredo's work in developing porphyrin derivatives for photodynamic therapy showcases his commitment to advancing medical science. His contributions have the potential to significantly improve treatment options for various diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…